Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 30, Issue 7, Pages 1206-1219
Publisher
American Society of Nephrology (ASN)
Online
2019-06-22
DOI
10.1681/asn.2018121254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
- (2018) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CD38-NAD + Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
- (2018) Shilpak Chatterjee et al. Cell Metabolism
- Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients
- (2018) Christopher K. Burghuber et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis
- (2017) Miriam Manook et al. LANCET
- IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
- (2017) Stanley C. Jordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study
- (2017) Marie Matignon et al. PLoS One
- Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology
- (2016) C. K. Burghuber et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
- (2016) A. Loupy et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
- (2016) J. Krejcik et al. BLOOD
- Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
- (2016) Sagar Lonial et al. LANCET
- Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies
- (2016) Tristan Legris et al. Frontiers in Immunology
- Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
- (2014) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- New insights regarding chronic antibody-mediated rejection and its progression to transplant glomerulopathy
- (2014) Carrie A. Schinstock et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients
- (2014) Chisa Yamada et al. TRANSFUSION
- Costimulation Blockade Alters Germinal Center Responses and Prevents Antibody-Mediated Rejection
- (2013) E. J. Kim et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
- (2013) Alexandre Loupy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five-Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch
- (2012) A. Bentall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The role of complement in antibody-mediated rejection in kidney transplantation
- (2012) Mark D. Stegall et al. Nature Reviews Nephrology
- Mechanisms of Rejection: Current Perspectives
- (2011) Kathryn J. Wood et al. TRANSPLANTATION
- KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif
- (2011) Arnaud D. Colantonio et al. PLoS Pathogens
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- (2010) M. de Weers et al. JOURNAL OF IMMUNOLOGY
- Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term Outcomes
- (2009) A. Haririan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- B-Cell–Depleting Induction Therapy and Acute Cellular Rejection
- (2009) Menna R. Clatworthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transplant Glomerulopathy: Risk and Prognosis Related to Anti-Human Leukocyte Antigen Class II Antibody Levels
- (2008) Naim Issa et al. TRANSPLANTATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started